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Diagnostic criteria and prevalence of mitral valve prolapse
After  the  ﬁrst  clinical  deﬁnition  of  mitral  valve  prolapse  (MVP),  based  on  the  typical  click
and  murmur  syndrome  [1], echocardiography  in  the  mid-1970s  introduced  a new  era  of  non-
invasive  diagnosis,  but  created  ambiguity  and  debate.  Using  the  initial  diagnostic  criteria,
the  prevalence  of  MVP  was  reported  to  be  as  high  as  5%  in  the  general  population  and  17%
in  some  population  groups  [2]. One  decade  later,  three-dimensional  work  [3]  furthered
our  understanding  of  mitral  annulus  morphology  and  the  contribution  of  its  saddle  shape
to  echocardiographical  patterns  previously  attributed  to  MVP.  Mitral  leaﬂets  can  appear
to  protrude  in  the  apical  four-chamber  view  without  actual  MVP,  the  echocardiographical
diagnosis  of  which  is  currently  based  upon  a  leaﬂet  overshoot  of  ≥  2  mm  in  long-axis  views
only  [4].  Whether  the  current  deﬁnition  should  be  restricted  to  protrusion  of  the  coapta-
tion  line,  as  emphasized  in  European  countries  (particularly  France),  or  applied  equally
to  posterior  displacement  of  either  the  tip  or  the  body  of  mitral  leaﬂets,  is  not  a  critical
issue,  as  it  does  not  affect  outcome,  which  is  determined  by  the  amount  of  mitral  regur-
gitation  (MR)  associated  with  MVP  [5].  This  clariﬁcation  of  diagnostic  criteria  was  crucial
for  redeﬁning  the  prevalence  of  MVP  in  the  population.  Although  considerably  lower  than
with  the  older  criteria,  the  prevalence  of  MVP  remains  high  (0.6—2.4%)  [4];  MVP  is  there-
fore  estimated  to  affect  more  than  150  million  subjects  worldwide,  which  highlights  the
importance  of  deﬁning  its  prognosis  comprehensively.
Abbreviations: EF, ejection fraction; LV, left ventricular; MIDA, Mitral Regurgitation International Database; MR, mitral regurgitation;
MVP, mitral valve prolapse.
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utcome of mitral valve prolapse: benign
r severe?
he  clinical  outcome  of  MVP  has  been  another  source  of
assionate  controversy  and  the  disease  has  been  consid-
red  successively  as  either  severe  [6,7]  or  uniformly  benign
4].  This  latter  statement  was  contradicted  by  surgical  and
athological  series  that  undeniably  established  MVP  as  the
eading  cause  of  severe  MR  requiring  surgery  in  Western
ountries  [8].
Methodological  issues  related  to  change  in  diagnostic
riteria  as  mentioned  above  and  selection  bias  in  the  refer-
al  of  either  the  most  severe  patients  in  tertiary  care
enters  [6,7]  or,  conversely,  the  healthiest  asymptomatic
olunteers  [4],  explain  parts  of  these  divergent  views.  Data
ased  on  all  community  patients  routinely  diagnosed  with
symptomatic  MVP  in  their  primary  care  hospital  using
odern  criteria  helped  to  reconcile  these  discordances.
he  data  highlighted  the  heterogeneity  of  the  disease,
he  prognosis  of  which  encompasses  a  wide  and  continu-
us  clinical  spectrum,  from  extremely  benign  to  severe,
epending  on  the  severity  of  mitral  regurgitation  at  diag-
osis  [5].  Approximately  half  of  MVP  patients  incur  high
ates  of  cardiovascular  complications,  including  mortality,
hen  signiﬁcant  MR  and/or  left  ventricular  (LV)  dysfunction
s  present,  whereas  half  (i.e.  those  with  no  MR  and  normal
V  function)  have  an  excellent  outcome.
In  addition,  these  community-based  analyses  allowed
lariﬁcation  of  the  disputed  role  of  MVP  in  the  occurrence
f  cryptogenic  stroke  in  young  patients,  which  varied  over
0  years  from  strong  [9]  to  absent  [10],  mainly  in  case-
ontrol  studies.  Comparison  of  observed  rates  of  ischemic
troke  in  community  MVP  patients  with  those  expected  in
he  same  community  showed  actual  excess  risk  of  ischemic
vents  attached  to  MVP,  but  conﬁned  to  elderly  patients  and
ot  observed  in  the  young.  Indeed,  older  age,  mitral  leaﬂet
hickening,  atrial  ﬁbrillation  and  mitral  surgery  were  the
ain  risk  factors  for  neurological  complications,  putting  MR
gain  at  the  centre  of  the  physiology  of  MVP  complications,
hrough  its  atrial  consequences  and  the  need  for  cardiac
urgery,  both  of  which  increase  with  ageing  [11].
utcome of severe regurgitation due to
itral valve prolapse: excess mortality or
enign? Impact of ageing on outcome
hese  community-based  data  were  in  total  agreement
ith  other  series  focusing  on  subsets  of  patients  with
evere  MR  due  to  ﬂail  leaﬂet  referred  to  tertiary  surgical
enters.  These  studies  consistently  reported  excess  mortal-
ty  under  conservative  management  compared  with  what
as  expected,  even  in  asymptomatic  patients  [12],  and
igh  morbidity,  including  atrial  ﬁbrillation  and  congestive
eart  failure,  both  in  the  USA  [12,13]  and  Europe  [14].
en  years  after  the  diagnosis  of  severe  MR  due  to  MVP,
0%  of  all  patients  were  dead  or  had  been  operated  on
or  severe  symptoms  [13,14],  highlighting  the  unavoidable
ature  of  surgery  in  the  course  of  the  disease.  Determi-
ants  of  adverse  outcome  under  conservative  management
ncluded  severe  symptoms,  decreased  LV  ejection  fraction
p
e
v
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EF),  increased  LV  end-systolic  diameter,  atrial  ﬁbrillation,
eft  atrial  remodeling,  pulmonary  artery  hypertension  and
ffective  regurgitant  oriﬁce  area  [12], which  are  therefore
onsidered  as  surgical  signals  [15]. However,  in  2006,  a  sin-
le  tertiary  care  centre  study  reported  excellent  outcome  in
32  asymptomatic  patients  with  severe  MR  due  to  MVP,  dis-
uting  the  severity  of  the  disease  while  asymptomatic  [16].
f  note,  besides  the  small  sample  size,  MR  was  not  quanti-
ed,  only  43%  of  all  patients  had  ﬂail  leaﬂet  and  importantly
he  mean  age  of  the  study  population  was  55  years  (i.e.  > 10
ears  younger  than  in  previous  community-based  studies
5]).
A  recent  study  from  the  Mitral  Regurgitation  Interna-
ional  Database  (MIDA)  aimed  to  further  understand  the
rigin  of  these  divergent  perceptions  [17].  The  MIDA  reg-
stry  provides  a  large  amount  of  multicenter  data  collected
n  ﬁve  centers  in  Europe  and  one  in  the  USA,  by  enrolling
n  routine  practice  patients  with  ﬂail  mitral  leaﬂet  used
s  a  model  of  pure  severe  organic  MR  [14,18].  This  study
ocused  on  the  clinical  outcome  under  conservative  mana-
ement  of  862  patients  with  ﬂail  leaﬂet,  who  were  mostly
symptomatic,  according  to  age  at  diagnosis.  Given  the  nor-
al  increase  in  complications  with  ageing  and  in  order  to
nalyze  the  impact  of  age  per  se  on  tolerance  of  severe
R,  the  study  compared  mortality  and  morbidity  rates
ith  those  expected  in  a  general  population  of  similar
ge  [17].  Despite  similar  echocardiographical  characteris-
ics  of  the  mitral  lesions  and  similar  indexed  LV  diameters
uggesting  similar  volume  overload  in  young  patients  as
n  older,  patients  aged  ≥  65  years  displayed  signiﬁcantly
igher  mortality  rates  vs  expected  mortality  in  the  gen-
ral  population,  whereas  this  difference  was  not  signiﬁcant
n  younger  patients.  This  observation  favors  the  hypothe-
is  of  decreased  tolerance  of  regurgitation  in  the  elderly
nd  offers  a plausible  explanation  for  lower  observed  mor-
ality  in  young  study  populations  [16].  Impaired  intrinsic
yocardial  anatomical  and  pathological  properties  of  the
ormal  aged  heart  could  result  in  reduced  LV  adaptation  to
olume  overload  in  older  patients.  Nevertheless,  although
ates  of  heart  failure  and  atrial  ﬁbrillation  increased  with
ge  at  diagnosis,  comparison  with  expected  rates  revealed
xcess  rates  of  both  events  in  the  youngest  age  group,  just
s  in  the  oldest  age  group.  Such  an  observation  in  young
atients  with  low  absolute  numbers  of  events  required  a
arge  population  and  could  easily  be  missed  by  smaller  sam-
les  [16].
In  summary,  these  data  support  the  hypothesis  that
xcess  risk  of  serious  non-fatal  complications  can  be
xpected  in  young  patients,  just  as  in  older  patients,  despite
he  absence  of  symptoms  and  normal  EF,  which  ultimately
eads  to  a  delayed  excess  mortality  becoming  signiﬁcant
ith  ageing.
arly surgery or watchful waiting?
he  conclusion  of  the  authors  of  the  unique  study  that
eported  a  benign  outcome  [16]  was  that  asymptomatic
atients  with  severe  MR  could  be  ‘‘safely  followed  until
ither  symptoms  occur  or  currently  recommended  cutoff
alues  for  LV  size,  LV  function  or  pulmonary  hypertension’’.
his  so-called  watchful  waiting  attitude  feeds  another
des  o
R
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[Mitral  regurgitation  due  to  mitral  valve  prolapse:  Four  deca
controversy  in  terms  of  surgical  management  of  severe
degenerative  MR  and  leads  part  of  the  cardiology  commu-
nity  to  support  a  symptom-waiting  attitude,  which  can  be
concerning  in  view  of  the  mediocre  postoperative  outcome
once  symptoms  have  occurred.
If  classical  risk  factors  of  adverse  outcome  under  medi-
cal  management  are  indisputable  surgical  signals  when
present,  they  have  indeed  been  associated  consistently
with  non-optimal  postoperative  results.  Severe  symptoms
[19],  atrial  ﬁbrillation  [20]  and  altered  LV  variables  [18,21]
are  not  only  independent  markers  of  adverse  outcome
under  medical  management  but  also  strong  risk  factors
for  impaired  postoperative  survival.  Excess  postoperative
mortality  in  such  patients  is  mostly  attributed  to  LV  dys-
function,  which  is  the  ﬁrst  cause  of  postoperative  mortality
[22]  and  is  barely  predicted  by  classic  preoperative  LV
variables  such  as  EF,  in  patients  with  altered  loading  con-
ditions.
Recent  data  [23]  from  the  MIDA  registry  showed  that
if  the  EF  is  <  60%,  long-term  mortality  increases  steeply
under  medical  or  surgical  management,  and  that  prognosis
becomes  catastrophic  if  the  EF  is  <  45%.  This  threshold  for
deﬁning  severe  LV  dysfunction  in  the  setting  of  severe  MR
seems  more  accurate  than  the  threshold  of  30%  mentioned
by  current  guidelines  [15],  as  the  latter  was  almost  never
observed  among  the  1875  patients  in  this  study  population.
Conversely,  above  60%,  no  further  EF  threshold  allowed  risk
stratiﬁcation,  underlining  that  this  variable  is  not  sensitive
for  detecting  subtle  LV  dysfunction,  as  suggested  by  the
signiﬁcant  proportion  of  patients  developing  postoperative
unexpected  LV  dysfunction  despite  strictly  normal  preoper-
ative  LVEF.
Altogether,  these  data  are  the  rationale  for  early  surgi-
cal  strategies,  along  with  the  development  of  mitral  repair,
which  is  feasible  in  the  vast  majority  of  cases  and  has
become  the  cornerstone  of  modern  management  of  severe
degenerative  MR.
These  strategies  were  conﬁrmed  by  a  ﬁnal  MIDA  paper,
reporting  the  clinical  outcome  of  1021  ﬂail  leaﬂet  patients
without  class  I  indications,  according  to  surgical  strategies.
The  long-term  survival  of  446  patients  with  mitral  surgery
performed  within  3  months  after  detection  of  MR  was  sig-
niﬁcantly  higher  and  the  incidence  of  heart  failure  was
lower  compared  with  575  patients  managed  medically  ini-
tially.  This  superiority  of  early  surgical  strategy  remained
signiﬁcant  after  propensity  score  adjustment  and  the  ben-
eﬁt  appeared  to  be  sustained  20  years  after  diagnosis
[24].
Of  note,  these  results  were  obtained  in  institutions  pro-
viding  high  valve  repair  rates  and  low  operative  mortality
rates,  which  emphasizes  that  advanced  repair  centers  are
required  to  achieve  such  results.  Reciprocity  of  interac-
tions  between  reconstructive  surgery  and  early  indications
is  clear:  mitral  valve  repair  is  the  necessary  condition  for
early  strategies,  which  themselves  ensure  the  best  results
of  mitral  reconstruction.Disclosure of interest
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cerning  this  article.
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